Quantifying nanotherapeutic penetration using hydrogel based microsystem as a new 3D in vitro platform - Archive ouverte HAL Access content directly
Journal Articles Lab on a Chip Year : 2021

Quantifying nanotherapeutic penetration using hydrogel based microsystem as a new 3D in vitro platform

Abstract

Abstract The huge gap between 2D in vitro assays used for drug screening, and the in vivo 3D-physiological environment hampered reliable predictions for the route and accumulation of nanotherapeutics in vivo. For such nanotherapeutics, Multi-Cellular Tumour Spheroids (MCTS) is emerging as a good alternative in vitro model. However, the classical approaches to produce MCTS suffer from low yield, slow process, difficulties in MCTS manipulation and compatibility with high-magnification fluorescent optical microscopy. On the other hand, spheroid-on-chip set-ups developed so far require a microfluidic practical knowledge difficult to transfer to a cell biology laboratory. We present here a simple yet highly flexible 3D-model microsystem consisting of agarose-based microwells. Fully compatible with the multi-well plates format conventionally used in cell biology, our simple process enables the formation of hundreds of reproducible spheroids in a single pipetting. Immunostaining and fluorescent imaging including live high-resolution optical microscopy can be performed in-situ , with no manipulation of spheroids. As a proof-of-principle of the relevance of such in vitro platform for nanotherapeutics evaluation, this study investigates the kinetic and localization of nanoparticles within colorectal cancer MCTS cells (HCT-116). The nanoparticles chosen are sub-5 nm ultrasmall nanoparticles made of polysiloxane and gadolinium chelates that can be visualized in MRI (AGuIX ® , currently implicated in clinical trials as effective radiosensitizers for radiotherapy) and confocal microscopy after addition of Cy 5.5. We show that the amount of AGuIX ® nanoparticles within cells is largely different in 2D and 3D. Using our flexible agarose-based microsystems, we are able to resolve spatially and temporally the penetration and distribution of AGuIX ® nanoparticles within MCTS. The nanoparticles are first found in both extracellular and intracellular space of MCTS. While the extracellular part is washed away after few days, we evidenced intracellular localisation of AGuIX ® , mainly within lysosomes compartment, but also occasionally within mitochondria. Our agarose-based microsystem appears hence as a promising 3D in vitro user-friendly platform for investigation of nanotherapeutics transport, ahead of in vivo studies. Abstract Figure Graphical abstract
Fichier principal
Vignette du fichier
d1lc00192b.pdf (9.17 Mo) Télécharger le fichier
d1lc90127c.pdf (1.37 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Licence : CC BY NC - Attribution - NonCommercial
Licence : CC BY - Attribution
Comment : Correction

Dates and versions

hal-03267425 , version 1 (04-10-2021)

Identifiers

Cite

Saba Goodarzi, Audrey Prunet, Fabien Rossetti, Guillaume Bort, Olivier Tillement, et al.. Quantifying nanotherapeutic penetration using hydrogel based microsystem as a new 3D in vitro platform. Lab on a Chip, 2021, 21 (13), pp.2495-2510. ⟨10.1039/D1LC00192B⟩. ⟨hal-03267425⟩
77 View
41 Download

Altmetric

Share

Gmail Facebook X LinkedIn More